For the first time the Food and Drug Administration (FDA) has approved a drug specifically designed for those who wake up at night, and difficulty returning to sleep.
The medications are manufactured in California, Intermezzo, a transept Pharmaceuticals is a low-dose formulation of zolpidem. Approved for the first time in 1992 in the United States, and is best known as the treatment of insomnia environment. "This is the first drug approved by FDA for this disease," spokesman for the federal government in a statement quoted by Channel News Asia, on Thursday (24/11).
He added Intermezzo to be used only when a person has time to sleep at least 4 hours and should not drink, because alcohol was consumed.
The recommended dose is 3.5 milligrams for men and half women. This is because the results of clinical trials have shown that zolpidem cleaning process of the female body more slowly than men.
"At low doses, the risk of having too much drugs in the body can cause drowsiness after awakening dangerous," says Robert Temple, Center for Drug Evaluation and Research, FDA. (Pri/OL-06)
0 comments:
Post a Comment